TNDM
NASD Tandem Diabetes Care, Inc.$16.45 ↑ +0.00 (+0.00%) Trading Up from the previous close of $16.45, $0.46 below the day’s high of $16.91
- YTD change
- -25.16%
- vs 20-day SMA
- -0.23%
- vs 200-day SMA
- -14.69%
Price ranges
Price & Performance
-3.65 (-18.16%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 89.4% away from all-time highs of $155.86
- TNDM is down 25% since the beginning of the year
- TNDM is up 17% over the past 12 months
- TNDM is down 4% over the past 1 month
- 18% of all TNDM investors are betting against TNDM
TNDM reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +18.6%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -0.30%
- vs 8-day SMA
- +1.53%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.